PB 81 of 2015
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 7) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated         25 August 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 7) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 81 of 2015.
 
2          Commencement
 
This Instrument commences on 1 September 2015.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
 
Schedule 1        Amendments
 
[1]           Schedule 1, after entry for Famotidine in the form Tablet 40 mg
insert:
Febuxostat
Tablet 80 mg
Oral
28
5